… antipseudomonas antibiotic therapy. Alongside the more traditional routes of administration
(oral or IV), aerosol delivery has become a notable complementary strategy [3, 4]. …

… With an established role in cystic fibrosis and bronchiectasis, nebulized antibiotics are
increasingly being used to treat respiratory infections in critically ill invasively mechanically …

… of inhaled antibiotics for the treatment of non-cystic fibrosis … trials (RCTs) on inhaled
antibiotics in treatment of NCFB from … efficacy and safety of inhaled antibiotics in the treatment of …

… inhaled antibiotic therapy, where two antibiotics are inhaled in … that continuous alternating
inhaled antibiotic therapy can … compared to intermittent use of antibiotics at time of exacerbation…

… inhaled antibiotics and Aspergillus colonization [24,27,28]. Despite this, aerosolized antibiotics
… ,42] and we do not suggest that inhaled antibiotics use should be curtailed. Instead, these …

… Prior to the start of inhaled antibiotic treatment, all patients … were initially treated with inhaled
antibiotic monotherapy (IAMT… that alternated 2 different inhaled antibiotics every 28 days (…

… Although there are references to the use of inhaled penicillin as early … inhaled antibiotics
was first reported in cystic fibrosis (CF) patients in 1981. In critical care, endotracheal antibiotic …

… the clinical efficacy of inhaled antibiotics can be reduced by many factors after deposition in
the airways. Aminoglycosides were the most extensively studied antibiotic and are adversely …

… We hypothesize for those individuals currently taking prescribed nebulized anti-pseudomonal
antibiotics that continuation of this therapy while away may additionally and inadvertently …

… on inhaled antibiotics are mainly focused on ventilator-associated pneumonia (VAP), cystic
fibrosis (… The efficacy and safety of inhaled antibiotics in these diseases have already been …